Bi-weekly capecitabine and oxaliplatin plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer
收藏NIAID Data Ecosystem2026-03-07 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2622609
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: Bi-weekly XELOX+bevacizumab
Primary outcome(s): Progression free survival
Study Design: Single arm Non-randomized
创建时间：
2012-01-15
